Promiliad Biopharma Incorporated (c) 2007 2011 September - TechGrowth Ohio and Southern Ohio Creates Companies (SOCC) have made a pre-seed investment in Promiliad to help develop... DHFR inhibitors as a treatment for antibiotic resistant infections. July - Promiliad has executed an exclusive license with the University of Connecticut to develop a novel class... of Health to develop novel antifolates as therapeutics for the treatment of MRSA. August Promiliad has been awarded a Phase I SBIR grant from the National Institutes of Health. The...

arrays. Promiliad has developed a proprietary and unique approach to the drug discovery process, a technology called ReBACS (Recombinant Biotechnology Assisted Combinatorial Synthesis.... Based on our natural product-like compound arrays, Promiliad Biopharma has established internal drug discovery programs that are focused on the development of new antibacterial and antifungal agents. ...

at the interface of synthetic chemistry and natural product fermentation. Our efforts are focused on the discovery and development of novel small molecule therapeutics that address...